Patent · US Active

Genome engineering

US11306328B2 · kind B2 · utility

1Cited by
2References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 30, 2014
Grant dateApr 19, 2022
Priority date
Expiry dateJun 30, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/003
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods are provided for altering target DNA in a cell genetically modified to express a Cas 9 enzyme that forms a co-localization complex with a guide RNA complementary to the target DNA and that cleaves the target DNA in a site specific manner. Methods include introducing into the cell a first foreign nucleic acid encoding a donor nucleic acid sequence, introducing into the cell from media surrounding the cell the guide RNA complementary to the target DNA and which guides the Cas 9 enzyme to the target DNA, wherein the RNA and the enzyme are members of a co-localization complex for the target DNA, wherein the donor nucleic acid sequence is expressed, wherein the guide RNA and the Cas 9 enzyme co-localize to the target DNA, the Cas 9 enzyme cleaves the target DNA and the donor nucleic acid is inserted into the target DNA to produce altered DNA in the cell.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.